Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report
Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report
复制标题
DOI：
10.1007/s00701-022-05384-7
复制
发表时间：
2022-10-15
影响因子：
2.4
通讯作者：
Saito，Nobuhito
中科院分区：
文献类型：
--
作者：
Umekawa，Motoyuki;Saito，Keita;Saito，Nobuhito
泪腺多形性腺瘤 (LGPA) 是常见的良性眼眶内肿瘤，可引起眼球突出、上睑下垂和视力障碍。 LGPA 的治愈性治疗是全切除，放疗被认为是复发的辅助疗法或无法手术的 LGPA 的替代疗法。立体定向放射外科 (SRS) 可用于向肿瘤精确输送高辐射剂量，这对于颅内和颅外肿瘤的治疗至关重要。在这里，我们介绍一位 95 岁的女性，她患有快速生长的复发性 LGPA，并成功接受了 SRS 治疗。 SRS 后 21 个月内肿瘤得到控制，没有出现任何不良事件。 SRS 是治疗复发性 LGPA 的一种潜在替代疗法。
Lacrimal gland pleomorphic adenomas (LGPAs) are common, benign, and intraorbital tumours that cause exophthalmos, ptosis, and visual disturbances. The curative treatment for LGPAs is gross total resection, and radiotherapy is considered adjunctive for recurrence or an alternative for inoperable LGPAs. Stereotactic radiosurgery (SRS) can be used for precise delivery of high radiation doses to the tumour, crucial in the treatment of intra-and extracranial neoplasms. Here, we present a 95-year-old woman who had a rapidly growing, recurrent LGPA and was successfully treated with SRS. The tumour was controlled without any adverse events over 21 months following SRS. SRS is a potential alternative treatment for recurrent LGPA.